INDUSTRY INSIGHTS YOUR PEERS ARE READING
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset MORE
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. MORE
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S. MORE
Health Consumers Health costs Medicines Patient engagement Personal health finance Pharmaceutical Pharmacy Popular culture and health MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
261 
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned. MORE
National health spending in the U.S. is expected to grow by 5.7% MORE
“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”. MORE
Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes. MORE
What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four? MORE
Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections. MORE
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People MORE
Looking at this photo of the 2020 Democratic Party Presidential candidate debater line-up might give you a déjà vu feeling, a repeat of the night-before debate. MORE
Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute. MORE
The technology has a built-in sensor that can send usage data to a corresponding smartphone app. MORE
198 
It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart. MORE
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses. MORE
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. MORE
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. MORE
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs MORE
Americans consumed 17.6 prescriptions per person in 2018, two in three of which treated chronic conditions. Welcome to Medicine Use and Spending in the U.S. , the annual review of prescription drug supply, demand and Rx pricing dynamics from the IQVIA Institute for Human Data Science. MORE
Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love. MORE
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients MORE
270 
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers. MORE
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards. MORE
But electronic prescribing alone doesn’t solve the Holy Grail challenge for both the pharmaceutical industry and providers: medication adherence. MORE
Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found. MORE
EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives. MORE
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. MORE
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores. MORE
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
203 
My take on drug reimportation, which I’ve discussed here on Health Populi, is that if Prime Minister Trudeau can negotiate drug prices with pharmaceutical companies, why shouldn’t President Trump — or previous Presidents of the U.S. MORE
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. MORE
Gallup notes that Americans are over two times more likely to rank the pharmaceutical industry negatively (58%) as positively (27%). “The pharmaceutical industry’s U.S. from Gallup’s 2019 survey into Americans’ Views of U.S. Business Industry Sectors. MORE
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs). MORE
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019. MORE
She is concerned about “kicking half of America off of health insurance in 4 years,” pivoting to the “much bigger issue” of pharmaceuticals pricing. MORE
Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S. MORE
Health care is the top issue facing the U.S. today, one in three Americans says, with another one-fourth pointing to the economy. Together, health care + the economy rank the top issues for 62% of Americans. MORE
Pharmaceuticals Related Topics 
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Mobi Health News
JULY 15, 2019
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.
Electronic Health Reporter
AUGUST 28, 2018
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.
Lloyd Price
NOVEMBER 26, 2018
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People
Healthcare Guys
JANUARY 30, 2019
Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections.
|
Health Populi
JULY 15, 2019
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores.
Health Populi
JULY 16, 2019
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute.
Health Populi
APRIL 10, 2019
Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute.
Health Populi
JULY 11, 2019
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses.
Health Populi
APRIL 17, 2019
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0.
|
|
Health Populi
AUGUST 7, 2019
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019.
Health Populi
JUNE 27, 2019
She is concerned about “kicking half of America off of health insurance in 4 years,” pivoting to the “much bigger issue” of pharmaceuticals pricing.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned.
Health Populi
JULY 2, 2019
My take on drug reimportation, which I’ve discussed here on Health Populi, is that if Prime Minister Trudeau can negotiate drug prices with pharmaceutical companies, why shouldn’t President Trump — or previous Presidents of the U.S.
Health Populi
MARCH 29, 2019
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S.
Mobi Health News
JUNE 23, 2019
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients
FierceHealthIT
JUNE 22, 2018
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset
Health Populi
APRIL 24, 2019
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population.
Health Populi
DECEMBER 25, 2018
Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love.
Health Populi
JANUARY 29, 2019
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs
Health Populi
FEBRUARY 21, 2019
National health spending in the U.S. is expected to grow by 5.7%
Health Populi
JUNE 18, 2019
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards.
Health Populi
MARCH 6, 2019
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them.
Health Populi
JUNE 28, 2019
Looking at this photo of the 2020 Democratic Party Presidential candidate debater line-up might give you a déjà vu feeling, a repeat of the night-before debate.
Health Populi
JUNE 4, 2019
Health Populi
AUGUST 7, 2018
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.
Health Populi
APRIL 26, 2019
It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart.
Health Populi
MAY 19, 2019
Health care is the top issue facing the U.S. today, one in three Americans says, with another one-fourth pointing to the economy. Together, health care + the economy rank the top issues for 62% of Americans.
Health Populi
MAY 8, 2019
Americans consumed 17.6 prescriptions per person in 2018, two in three of which treated chronic conditions. Welcome to Medicine Use and Spending in the U.S. , the annual review of prescription drug supply, demand and Rx pricing dynamics from the IQVIA Institute for Human Data Science.
Health Populi
FEBRUARY 10, 2019
But electronic prescribing alone doesn’t solve the Holy Grail challenge for both the pharmaceutical industry and providers: medication adherence.
Health Populi
AUGUST 6, 2018
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.
Health Populi
SEPTEMBER 16, 2018
Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found.
Health Populi
MARCH 15, 2018
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).
Health Populi
MAY 22, 2018
What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?
Health Populi
MAY 29, 2018
“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”.
Health Populi
JUNE 28, 2018
EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives.
Health Populi
AUGUST 8, 2018
Health Consumers Health costs Medicines Patient engagement Personal health finance Pharmaceutical Pharmacy Popular culture and health
Health Populi
JUNE 5, 2018
Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes.
Health Populi
JUNE 7, 2018
Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.
Let's personalize your content